GLP-1 (glucagon-like peptide-1) receptor agonists are a class of peptides studied for their effects on appetite regulation, glucose homeostasis, and metabolic health. They have become a major focus of modern peptide research.
Mechanism of Action
GLP-1 agonists bind to GLP-1 receptors in the pancreas, gut, and brain. In research models, this activation has been linked to enhanced insulin secretion, delayed gastric emptying, and reduced appetite signaling.
Research Applications
- Metabolic syndrome and obesity models
- Glycemic control and insulin sensitivity studies
- Neuroendocrine appetite regulation
RoWellness offers GLP-1 research peptides including GLP-Reta, Semaglutide, and Tirzepatide for qualified laboratory research.